表纸
市场调查报告书

全球药物洗脱支架市场

Global Drug-Eluting Stents Market

出版商 BCC Research 商品编码 969286
出版日期 内容资讯 英文 127 Pages
订单完成后即时交付
价格
全球药物洗脱支架市场 Global Drug-Eluting Stents Market
出版日期: 2020年11月04日内容资讯: 英文 127 Pages
简介

全球药物洗脱支架市场预计将以6.8%的复合年增长率增长,从2019年的67亿美元增长到2024年的93亿美元。

本报告分析了全球药物洗脱支架市场,并概述了产品和技术,市场的基本结构,主要的市场推广/限制因素以及市场规模/增长率/市场份额趋势(过去)。 2年/未来5年),按地区/产品/用途/最终用户划分的详细趋势,法规制定/技术发展的动态,主要公司的概况,新冠状病毒感染的影响(Covid-19)等等。将被收集并交付。

目录

第1章简介

第2章摘要要点

第3章医疗器械法规

  • 医疗设备的定义和分类
  • 世界各地的法规(美国/欧洲/日本)

第4章药物洗脱支架:管道分析

  • 概述

第5章药物洗脱支架:市场背景

  • 简介
  • 市场历史
  • 涂料和聚合物
  • DES中使用的药物
  • 心血管疾病(CVD)
  • CVD的一般类型
  • CVD症状
  • CVD危险因素
  • CVD处理方法

第6章药物洗脱支架:市场动态

  • 市场动态
  • 市场促进因素
  • 市场约束因素

第7章感染传播的新冠状病毒感染(COVID-19)的影响

  • 简介
  • 爆发
  • COVID-19的症状
  • COVID-19的进展
  • 潜伏期
  • 流行病学
  • 世界范围内确诊的COVID-19病例和死亡人数
  • 各种组织与政府之间的合作
  • 疾病流行
  • 现状和对医疗IT公司的影响(MedTech)
  • 备用手术(选择性/非重要程序)
  • 制造业转移
  • 延迟监管,临床试验,产品上市
  • 供应链中断
  • 医疗旅游

第8章按产品分类的市场

  • 全球药物洗脱支架市场:按产品
  • 聚合物基药物洗脱支架
    • 市场规模和预测
    • 市场分析
  • 无聚合物洗脱药物支架

第9章按应用细分市场

  • 全球药物洗脱支架市场:按应用
  • 冠状动脉疾病(CAD)
  • 周围动脉疾病(PAD)

第10章按最终用户划分的细分市场

  • 全球药物洗脱支架市场:按最终用户划分
  • 医院
  • 门诊手术中心
  • 专科中心诊所

第11章按地区划分市场

  • 全球药物洗脱支架市场:按地区
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 其他亚太国家
  • 拉丁美洲
  • 中东/非洲

第12章竞争情况

  • 全球公司份额分析
  • 企业合并/收购(并购)
  • 协议,业务合作/合作,产品发布

第13章公司简介

  • ABBOTT
  • ALVIMEDICA
  • B. BRAUN MELSUNGEN AG
  • BIOSENSORS INTERNATIONAL
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • COOK MEDICAL INC.
  • LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
  • MEDTRONIC PLC
  • TERUMO CORP.

第14章附录:首字母缩写词列表

目录
Product Code: MDS026A

Highlights:

The global market for drug-eluting stents should grow from $6.7 billion in 2019 to $9.3 billion by 2024 at a compound annual growth rate (CAGR) of 6.8% during the period of 2019-2024.

The global market for polymer-based drug-eluting stents should grow from $4.1 billion in 2019 to $5.4 billion by 2024 at a CAGR of 6.0% during the period of 2019-2024.

The global market for polymer-free drug-eluting stents should grow from $2.7 billion in 2019 to $3.9 billion by 2024 at a CAGR of 7.9% during the period of 2019-2024.

Report Scope:

This report examines the current and projected market potential of drug-eluting stents. It offers a detailed analysis of the regulatory scenario, competitive environment, pipeline, technological advancement, drivers, restraints and market growth trends. The report also includes market projections through 2024 and the market rank for key market players. The report details the market share of drug-eluting stents based on types of product, application and end user.

By product type, the market is segmented into polymer-based drug-eluting stents and polymer-free drug-eluting stents. By application, the market is segmented into coronary artery disease (CAD) and peripheral artery disease (PAD). By end user, the market is segmented into hospitals, ambulatory surgical centers and specialty centers and clinics.

By geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for 2018 as the base year, 2019 and forecast through year-end 2024. Estimated values used are based on drug-eluting stent manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

  • 20 data tables and 18 additional tables
  • An overview of global market for drug-eluting stents within the medical devices industry
  • Estimation of the market size and analyses of market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Market share analysis of the drug-eluting stents based on product, application, end-use, and region
  • Identification of segments with high growth potential and analysis of future applications of each of the segments
  • Assessment of market dynamics for drug-eluting stents with market drivers and restraints explained, medical device regulations, market background and pipeline analysis of the stents
  • Coverage of prevalence and epidemiology of cardiovascular disease and description of coronary artery disease (CAD) and peripheral artery disease (PAD)
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of the leading market players, including Abbott, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp., Medtronic Plc and Cook Medical Inc.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Market Highlights: Drug-Eluting Stents

Chapter 3: Medical Device Regulations

  • Medical Device Definition and Classification
  • Regulations in the U.S.
  • Code of Federal Regulations
  • Regulations in Europe
  • Regulations in Japan

Chapter 4: Drug-Eluting Stents: Pipeline Analysis

  • Overview

Chapter 5: Drug-Eluting Stents: Market Background

  • Introduction
  • Market Evolution
  • Coating and Polymers
  • Drugs Used in DESs
  • Cardiovascular Diseases (CVDs)
  • Common Types of CVD
  • Symptoms of CVD
  • Risk Factors: CVD
  • Treatment for CVD

Chapter 6: Drug-Eluting Stents: Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Market Restraints

Chapter 7: Impact of COVID-19 Pandemic

  • Introduction
  • Outbreak
  • Symptoms of COVID-19
  • Progression of COVID-19
  • Incubation Period
  • Epidemiology
  • Global Confirmed COVID-19 Cases and Deaths
  • Collaboration Between Organizations and Governments
  • Spread of Disease
  • Current Status and Impact on MedTech
  • Elective and Noncritical Procedures
  • Shift in Manufacturing
  • Regulatory Delays, Clinical Trials and Product Launches
  • Supply Chain Disruptions
  • Medical Tourism

Chapter 8: Market Breakdown, by Product

  • Global Market for Drug-Eluting Stents, by Product
  • Polymer-Based Drug-Eluting Stents
  • Market Size and Forecast
  • Market Analysis
  • Polymer-Free Drug-Eluting Stents
  • Market Size and Forecast
  • Market Analysis

Chapter 9: Market Breakdown, by Application

  • Global Market for Drug-Eluting Stents, by Application
  • Coronary Artery Disease (CAD)
  • Market Size and Forecast
  • Market Analysis
  • Peripheral Artery Disease (PAD)
  • Market Size and Forecast
  • Market Analysis

Chapter 10: Market Breakdown, by End User

  • Global Market for Drug-Eluting Stents, by End User
  • Hospitals
  • Market Size and Forecast
  • Market Analysis
  • Ambulatory Surgical Centers
  • Market Size and Forecast
  • Market Analysis
  • Specialty Centers and Clinics
  • Market Size and Forecast
  • Market Analysis

Chapter 11: Market Breakdown, by Region

  • Global Market for Drug-Eluting Stents, by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa

Chapter 12: Competitive Landscape

  • Global Company Share Analysis
  • Mergers and Acquisitions
  • Agreements, Collaborations, Product Launches and Partnerships

Chapter 13: Company Profiles

  • ABBOTT
  • ALVIMEDICA
  • B. BRAUN MELSUNGEN AG
  • BIOSENSORS INTERNATIONAL
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • COOK MEDICAL INC.
  • LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
  • MEDTRONIC PLC
  • TERUMO CORP.

Chapter 14: Appendix: List of Acronyms

List of Tables

  • Summary Table A: Global Market for Drug-Eluting Stents, by Product, Through 2024
  • Summary Table C: Global Market for Drug-Eluting Stents, by End User, Through 2024
  • Summary Table B: Global Market for Drug-Eluting Stents, by Application, Through 2024
    • Table 1: Class I and II Exempt Devices
    • Table 2: Selected Clinical Trial Studies: Drug-Eluting Stents
    • Table 3: Selected Coronary Stents
    • Table 4: Drugs Commonly Used in DES
    • Table 5: CVD Risk Factors
    • Table 6: Coronary Angioplasty Procedures, by Country, 2018
    • Table 7: Distribution of COVID-19 Symptoms
    • Table 8: COVID-19: Confirmed Cases and Deaths, by Country, as of Aug. 3, 2020
    • Table 9: Global Market for Drug-Eluting Stents, by Product Segment, Through 2024
    • Table 10: Common Polymers Used in DES
    • Table 11: Coating Methods to Develop Polymer-Free Drug-Eluting Stents
    • Table 12: Global Market for Drug-Eluting Stents, by Application, Through 2024
    • Table 13: Global Market for Drug-Eluting Stents, by End User, Through 2024
    • Table 14: Global Market for Drug-Eluting Stents, by Region, Through 2024
    • Table 15: North American Market for Drug-Eluting Stents, by Country, Through 2024
    • Table 16: Estimated Number of U.S. Stent Procedures, by Type of Procedure, 2014
    • Table 17: European Market for Drug-Eluting Stents, by Country, Through 2024
    • Table 18: Asia-Pacific Market for Drug-Eluting Stents, by Country, Through 2024
    • Table 19: Latin American Market for Drug-Eluting Stents, by Product, Through 2024
    • Table 20: Latin American Market for Drug-Eluting Stents, by Application, Through 2024
    • Table 21: Latin American Market for Drug-Eluting Stents, by End User, Through 2024
    • Table 22: Leading Causes of Death and Percentage Change in Argentina, 2007-2017
    • Table 23: Middle Eastern and African Market for Drug-Eluting Stents, by Product, Through 2024
    • Table 24: Middle Eastern and African Market for Drug-Eluting Stents, by Application, Through 2024
    • Table 25: Middle Eastern and African Market for Drug-Eluting Stent, by End User, Through 2024
    • Table 26: Global Market Shares of Drug-Eluting Stents, by Company, 2019
    • Table 27: Abbott: Drug-Eluting Stents, Product Portfolio
    • Table 28: Alvimedica: Drug-Eluting Stents, Product Portfolio
    • Table 29: B. Braun Melsungen AG: Drug-Eluting Stents, Product Portfolio
    • Table 30: Biosensors International: Drug-Eluting Stents, Product Portfolio
    • Table 31: Biotronik SE & Co. KG: Drug-Eluting Stents, Product Portfolio
    • Table 32: Boston Scientific Corp.: Drug-Eluting Stents, Product Portfolio
    • Table 33: Cook Medical Inc.: Drug-Eluting Stents, Product Portfolio
    • Table 34: Lepu Medical Technology (Beijing) Co., Ltd.: Drug-Eluting Stents, Product Portfolio
    • Table 35: Medtronic Plc: Drug-Eluting Stents, Product Portfolio
    • Table 36: Terumo Corp.: Drug-Eluting Stents, Product Portfolio
    • Table 37: Acronyms Used in the Drug-Eluting Stents Industry

List of Figures

  • Summary Figure C: Global Market for Drug-Eluting Stents, by Application, 2018-2024
  • Summary Figure B: Global Market Shares of Drug-Eluting Stents, by Product, 2019
  • Summary Figure A: Global Market for Drug-Eluting Stents, by Product, 2018-2024
  • Summary Figure D: Global Market Shares of Drug-Eluting Stents, by Application, 2019
  • Summary Figure E: Global Market for Drug-Eluting Stents, by End User, 2018-2024
  • Summary Figure F: Global Market Shares of Drug-Eluting Stents, by End User, 2019
    • Figure 1: Marketing a Medical Device in the U.S.
    • Figure 2: Historical Milestones: Coronary Artery Stenting
    • Figure 3: Global Disease Burden, 2017
    • Figure 4: Adults with Cardiovascular Conditions, by Country, 2019
    • Figure 5: Top 10 Global Causes of Deaths, 2016
    • Figure 6: Global Geriatric Population (Aged 65+ Years), 2014-2022
    • Figure 7: Surgical Operations Performed Globally, 2004 and 2012
    • Figure 8: Global Market Shares of Drug-Eluting Stents, by Product Segment, 2019
    • Figure 9: Global Market for Polymer-Based Drug-Eluting Stents, 2018-2024
    • Figure 10: Global Market for Polymer-Based Drug-Eluting Stents, by Region, 2018-2024
    • Figure 11: Global Market for Polymer-Free Drug-Eluting Stents, 2018-2024
    • Figure 12: Global Market for Polymer-Free Drug-Eluting Stents, by Region, 2018-2024
    • Figure 13: Global Market Shares of Drug-Eluting Stents, by Application, 2019
    • Figure 14: Global Market for Coronary Artery Disease, 2018-2024
    • Figure 15: Global Market for Peripheral Artery Disease, 2018-2024
    • Figure 16: Global Market Shares of Drug-Eluting Stents, by End User, 2019
    • Figure 17: Global Market for Drug-Eluting Stents in Hospital End Use, 2018-2024
    • Figure 18: Global Market for Drug-Eluting Stents in Ambulatory Surgical Center End Use, 2018-2024
    • Figure 19: Global Market for Drug-Eluting Stents in Specialty Center and Clinic End Use, 2018-2024
    • Figure 20: Global Market Shares of Drug-Eluting Stents, by Region, 2019
    • Figure 21: North American Market Shares of Drug-Eluting Stents, by Country, 2019
    • Figure 22: U.S. Market for Drug-Eluting Stents, 2018-2024
    • Figure 23: U.S. Population Aged 65+, Projection and Trends, 2010-2050
    • Figure 24: Distribution of Deaths in the U.S. from CVD, by Disease Sub-Segment, 2016
    • Figure 25: Canadian Market for Drug-Eluting Stents, 2018-2024
    • Figure 26: European Market Shares of Drug-Eluting Stents, by Country, 2019
    • Figure 27: German Market for Drug-Eluting Stents, 2018-2024
    • Figure 28: U.K. Market for Drug-Eluting Stents, 2018-2024
    • Figure 29: French Market for Drug-Eluting Stents, 2018-2024
    • Figure 30: Italian Market for Drug-Eluting Stents, 2018-2024
    • Figure 31: Spanish Market for Drug-Eluting Stents, 2018-2024
    • Figure 32: Rest of European Market for Drug-Eluting Stents, 2018-2024
    • Figure 33: Asia-Pacific Market Shares of Drug-Eluting Stents, by Country, 2019
    • Figure 34: Japanese Market for Drug-Eluting Stents, 2018-2024
    • Figure 35: Chinese Market for Drug-Eluting Stents, 2018-2024
    • Figure 36: Shares of Major Causes of Death in Rural China, 2016
    • Figure 37: Shares of Major Causes of Death in Urban China, 2016
    • Figure 38: Indian Market for Drug-Eluting Stents, 2018-2024
    • Figure 39: Rest of Asia-Pacific Market for Drug-Eluting Stents, 2018-2024
    • Figure 40: Latin American Market for Drug-Eluting Stents, 2018-2024
    • Figure 41: Latin American Market Shares of Drug-Eluting Stents, by Product, 2019
    • Figure 42: Middle Eastern and African Market for Drug-Eluting Stents, 2018-2024
    • Figure 43: Middle Eastern and African Market Shares of Drug-Eluting Stents, by Product, 2019
    • Figure 44: Abbott: Annual Revenue, 2017-2019
    • Figure 45: Abbott: Revenue Share, by Country, 2019
    • Figure 46: Abbott: Revenue Share, by Product Category, 2019
    • Figure 47: B. Braun Melsungen AG: Annual Revenue, 2017-2019
    • Figure 48: B. Braun Melsungen AG: Revenue Share, by Business Division, 2019
    • Figure 49: B. Braun Melsungen AG: Revenue Share, by Country/Region, 2019
    • Figure 50: Boston Scientific Corp.: Annual Revenue, 2017-2019
    • Figure 51: Boston Scientific Corp.: Revenue Share, by Product Category, 2019
    • Figure 52: Boston Scientific Corp.: R&D Expenditures, 2017-2019
    • Figure 53: Lepu Medical Technology (Beijing) Co., Ltd.: Annual Revenue, 2017-2019
    • Figure 54: Medtronic Plc: Annual Revenue, 2017-2019
    • Figure 55: Medtronic Plc: Revenue Share, by Country/Region, 2019
    • Figure 56: Medtronic Plc: Revenue Share, by Product Category, 2019
    • Figure 57: Terumo Corp.: Annual Revenue, 2017-2019
    • Figure 58: Terumo Corp.: Revenue Share, by Product Category, 2019